	La Marge Brute Sur Les Ventes		Date
AbbVie	USD 10.47B	605M	2025-09
Alnylam Pharmaceuticals	USD 1.05B	418.14M	2025-09
Amarin	USD 22.21M	28.15M	2025-09
Amgen	USD 6.48B	307M	2025-09
Biogen	USD 1.65B	34.6M	2025-12
BioMarin Pharmaceutical	USD 631.2M	39.27M	2025-09
Cipla	INR 41.64B	6.31B	2025-12
CSL	USD 1.75B	2.53B	2025-06
Cytokinetics	USD 1.94M	64.83M	2025-09
Daiichi Sankyo	JPY 439.83B	95.05B	2025-12
Eli Lilly	USD 14.59B	1.48B	2025-09
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
Geron	USD 46.18M	1.66M	2025-09
Grifols	EUR 766.49M	39.74M	2024-12
Halozyme Therapeutics	USD 281.77M	2.41M	2025-09
Heron Therapeutics	USD 23.35M	1.6M	2024-09
Ionis Pharmaceuticals	USD 155M	293M	2025-09
Merck	USD 13.42B	431M	2025-09
Minerva Neurosciences	-4.27M	26.79M	2024-12
Moderna	USD 809M	791M	2025-09
Nektar Therapeutics	USD 13.75M	650K	2024-06
Pfizer	USD 3.54B	7.61B	2025-09
PTC Therapeutics	USD 187.69M	24.3M	2025-09
Puma Biotechnology	USD 20.32M	24.85M	2024-09
Regeneron Pharmaceuticals	USD 3.3B	67M	2025-12
Sanofi	EUR 8.45B	1.31B	2025-12
Sarepta Therapeutics	USD 247.9M	209.96M	2025-09
United Therapeutics	USD 602.1M	108.9M	2025-09
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12

Esperion Therapeutics La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.